- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04859998
Effects of Animal-assisted Therapy on the Physical Function and Communication of Adults With Autism
Effects of Animal-assisted Therapy on the Physical Function and Communication of Adults With Autism: a Controlled Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The intervention program will consist of 20 sessions conducted twice a week in the facilities of the collaborator associations. Each session will be conducted in groups of 3 participants and will last 30 minutes. It will include a welcome part, a main part (based on different activities and physical exercises with the dog) and a closing part to say goodbye to the dogs.
Physical function measures will be conducted before and after the completion of the study. The interaction and communication will be assessed during the sessions in the first, tenth and last ones.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Madrid
-
Móstoles, Madrid, Spain, 28933
- King Juan Carlos University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Older than 40 years
- With autism spectrum disorder
- Able to walk autonomously, without help from other people.
- Able to climb and descent stairs autonomously, without help from other people.
Exclusion Criteria:
- Medical condition that contraindicates the proximity or contact with the animals with the animals on the part of the user.
- Allergy to dog epithelium.
- Phobias to dogs.
- History of aggression to animals.
- Users who do not submit a signed informed consent form.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
Participants in this group will simply continue with their daily living and therapies.
They will be assessed before and after the 10 week program but will not take part in it.
|
|
|
Experimental: Experimental group
Participants in this group will take part in the 20 session dog-assisted therapy.
This therapy will be added to their usual daily living and therapies.
They will be assessed before and after the 10 week program.
|
It will consist of 20 sessions conducted twice a week in the facilities of the association.
It will involve different activities and physical exercises facilitated by the dogs.
The program will be conducted in two associations (12 participants in each one, 6 belonging to the experimental and 6 belonging to the control group in each association) and in groups of three participants.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in walking performance (10m)
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Evaluation of the ability to walk 10 meters in a corridor (time spent)
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
|
Changes in walking performance (6m)
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Evaluation of the ability to walk 6 meters in a corridor (time spent)
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in balance and risk of falling
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Using the Tinetti Assessment Tool.
Minimum score = 0. Maximum score for gait = 12 points; Maximum score for balance component = 16 points.
Maximum total score = 28 points.
Higher scores mean lower risk of falling.
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
|
Changes in communication without dog
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
An observation scale designed by the group to evaluate the interaction and communication with other people.
It is comprised by 14 items, scored as 1 (yes) and 0 (no).
Minimum score = 0; Maximum score = 14.
Higher scores mean higher communication.
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
|
Changes in communication with dog
Time Frame: During sessions (first, intermediate and last one)
|
An observation scale designed by the group to evaluate the interaction and communication with the dogs and other people.
It is comprised by 38 items, scored as 1 (yes) and 0 (no).
Minimum score = 0; Maximum score = 38.
Higher scores mean higher communication.
|
During sessions (first, intermediate and last one)
|
|
Changes in the ability to climb and descend stairs
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Evaluation of the ability to climb and descend stairs (10 steps)
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
|
Changes in step length (6m)
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Evaluation of the step length walking 6 meters in a corridor
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
|
Changes in step length (10m)
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Evaluation of the step length walking 10 meters in a corridor
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
|
Changes in cadence (6m)
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Evaluation of the cadence walking 6 meters in a corridor
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
|
Changes in cadence (10m)
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Evaluation of the cadence walking 10 meters in a corridor
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
|
Changes in duration of phases in the gait cycle (6m)
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Evaluation of the duration of phases in the gait cycle walking 6 meters in a corridor
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
|
Changes in duration of phases in the gait cycle (10m)
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Evaluation of the duration of phases in the gait cycle walking 10 meters in a corridor
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Daniel Collado-Mateo, PhD, Universidad Rey Juan Carlos
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AATinAutism
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCActive, not recruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
University of California, Los AngelesUniversity of WashingtonRecruitingAutism Spectrum Disorder (ASD)United States
Clinical Trials on dog-assisted therapy
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Hospital Infantil Universitario Niño Jesús, Madrid, Spain; Universidad Rey... and other collaboratorsCompletedMental Health IssueSpain
-
Daniel Collado-MateoAsociación Dame La PataRecruitingWork Related Stress | Occupational GroupsSpain
-
Daniel Collado-MateoPurina España (Reg. Trademark of Nestle S.A.)Enrolling by invitationEating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/BulimiaSpain
-
Fondation Bon Sauveur De La MancheNot yet recruiting
-
Kaiser PermanenteSeattle Children's HospitalActive, not recruitingPediatric Cancer, Animal-Assisted ActivitiesUnited States
-
The University of Hong KongHong Kong Correctional Services DepartmentRecruitingPsychological Wellbeing | Animal-assisted InterventionHong Kong
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
Taipei Veterans General Hospital, TaiwanCompletedTreatment | Prevention | Supportive CareTaiwan
-
Texas Tech UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedAutism Spectrum Disorder | Social SkillsUnited States
-
Koç UniversityNot yet recruitingQuality of Life | Fatigue | Sleep Quality